NL-OMON28389
Recruiting
Not Applicable
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up (BOOG 2013-08).
KWF, CZ, ZonMw0 sites1,644 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- breast neoplasms
- Sponsor
- KWF, CZ, ZonMw
- Enrollment
- 1644
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •2\. Aged 18 years or older
Exclusion Criteria
- •1\. Clinically node positive pre\-operative
- •2\. Bilateral breast cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial.breast cancersentinel lymph node metastasessentinel lymph nodes1000629110006295NL-OMON54499Medisch Universitair Ziekenhuis Maastricht1,730
Recruiting
Not Applicable
BOOG 2013-08: Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up.NL-OMON22593KWFCZZonMw1,644
Active, not recruiting
Phase 1
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-002039-28-ESSandoz GmbH308
Completed
Phase 3
A study to evaluate the Efficacy and Safety of LA-EP2006 and Neulasta® in patients with breast cancer.CTRI/2012/10/003065Sandoz GmbH302
Completed
Not Applicable
Too much, too soon? The impact of treatment-focused genetic testing in patients newly diagnosed with breast cancer.early or locally advanced breast cancerWomen at increased risk for carrying a faulty gene for breast and/or ovarian cancerCancer - BreastHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12610000502033Prince of Wales Hospital120